News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,432 Results
Type
Article (32068)
Company Profile (63)
Press Release (380301)
Section
Business (120189)
Career Advice (1343)
Deals (24859)
Drug Delivery (90)
Drug Development (59815)
Employer Resources (104)
FDA (10594)
Job Trends (9418)
News (220676)
Policy (25864)
Tag
Academia (1873)
Alliances (42886)
Alzheimer's disease (1015)
Approvals (10542)
Artificial intelligence (101)
Bankruptcy (235)
Best Places to Work (7917)
Breast cancer (131)
Cancer (994)
Cardiovascular disease (71)
Career advice (1130)
CAR-T (70)
Cell therapy (202)
Clinical research (47441)
Collaboration (378)
Compensation (200)
COVID-19 (2463)
C-suite (75)
Data (993)
Diabetes (131)
Diagnostics (3890)
Drug pricing (83)
Earnings (41715)
Employer resources (96)
Events (47239)
Executive appointments (225)
FDA (11074)
Funding (276)
Gene therapy (151)
GLP-1 (590)
Government (4047)
Healthcare (11812)
Infectious disease (2550)
Interviews (234)
IPO (10639)
Job creations (1827)
Job search strategy (975)
Layoffs (256)
Legal (7029)
Lung cancer (144)
Manufacturing (150)
Medical device (6912)
Medtech (6914)
Mergers & acquisitions (14339)
Metabolic disorders (383)
Neuroscience (1252)
NextGen Class of 2024 (3864)
Non-profit (2834)
Northern California (1113)
Obesity (233)
Opinion (174)
Parkinson's disease (70)
Patents (84)
People (28600)
Phase I (14320)
Phase II (20591)
Phase III (16699)
Pipeline (392)
Policy (72)
Postmarket research (1848)
Preclinical (5966)
Radiopharmaceuticals (201)
Rare diseases (179)
Real estate (2806)
Regulatory (16033)
Research institute (1657)
Resumes & cover letters (198)
Southern California (877)
Startups (1976)
United States (8953)
Vaccines (594)
Weight loss (187)
Date
Last 7 days (475)
Last 30 days (1725)
Last 365 days (23451)
2024 (22880)
2023 (26441)
2022 (34933)
2021 (37614)
2020 (35635)
2019 (29363)
2018 (22291)
2017 (21359)
2016 (19781)
2015 (22801)
2014 (16832)
2013 (13756)
2012 (14768)
2011 (15516)
2010 (14013)
Location
Africa (576)
Arizona (81)
Asia (26224)
Australia (4692)
California (2334)
Canada (884)
China (210)
Colorado (100)
Connecticut (103)
Europe (64045)
Florida (328)
Georgia (79)
Illinois (208)
Indiana (140)
Maryland (466)
Massachusetts (1684)
Michigan (82)
Minnesota (110)
New Jersey (714)
New York (697)
North Carolina (394)
Northern California (1113)
Ohio (85)
Pennsylvania (532)
South America (811)
Southern California (877)
Texas (284)
Washington State (217)
412,432 Results for "jpk instruments ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Business
Alamar Biosciences and Biomarkers of Aging Consortium Join Forces to Revolutionize Longevity Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium announced the launch of the next phase of the Biomarkers of Aging Challenge Series.
June 27, 2024
·
3 min read
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
Sirona Biochem Corp. is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare’s newly published research report, “Novel Treatments for Age-Related Skin Problems.” The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market.
June 18, 2024
·
3 min read
Business
Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate - technology, announced the appointment of Ulf Grawunder, Ph.D. to its scientific advisory board.
June 13, 2024
·
3 min read
Press Releases
Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
November 26, 2024
·
4 min read
Press Releases
Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
November 27, 2024
·
5 min read
Pharm Country
NYU Langone Health’s New Optimal Aging Institute to Further Explore the Link Between Vascular Health and Aging
Researchers at the newly-formed Optimal Aging Institute at NYU Langone Health have been awarded $31 million by the National Institutes of Health for a diverse, ten university cohort to study how vascular risk factors contribute to dementia and other age-related disorders in those over the age of 85, building upon existing research.
April 11, 2024
·
6 min read
Press Releases
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
November 21, 2024
·
2 min read
Press Releases
Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk
November 5, 2024
·
7 min read
1 of 41,244
Next